Moxifloxacin: safety profile
The latest, so-called respiratory, fluoroquinolones are a group of antimicrobial agents (AMA), most commonly prescribed for community-acquired lower respiratory tract infection (caLRTI), which is a relevant issue in routine clinical practice.
主要作者: | A. I. Sinopalnikov |
---|---|
格式: | 文件 |
语言: | Russian |
出版: |
Remedium Group LLC
2013-12-01
|
丛编: | Медицинский совет |
主题: | |
在线阅读: | https://www.med-sovet.pro/jour/article/view/1152 |
相似书籍
-
Community-acquired pneumonia against a background of chronic heart failure: diagnosis and treatment
由: A. A. Bobylev, et al.
出版: (2014-12-01) -
Moxifloxacin in the treatment of community-acquired pneumonia in adults: what's new?
由: A. I. Sinopalnikov
出版: (2014-12-01) -
Rational therapy of patients with lower respiratory tract infections
由: V. A. Kazantsev
出版: (2013-12-01) -
Cough in children as a symptom of respiratory tract infections: a new look at the problem of antibiotic therapy
由: O. A. Egorova
出版: (2014-12-01) -
Местная иммуномодуляция при заболеваниях верхних дыхательных путей
出版: (2018-06-01)